Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
CLINICAL RESEARCH
The role of systemic inflammation in mediating the association between red cell distribution width/albumin ratio and all-cause and cardiovascular mortality in cardiovascular disease patients with diabetes or prediabetes: insights from a large, population-based study
1
Department of Cardiology, Affiliated Hospital of Zunyi Medical University, Zunyi, China
These authors had equal contribution to this work
Submission date: 2025-01-04
Final revision date: 2025-06-23
Acceptance date: 2025-06-29
Online publication date: 2025-08-05
Corresponding author
KEYWORDS
National Health and Nutrition Examination Surveyred cell distribution width/albumin ratiomortality riskinflammatory indicatorscardiovascular diseasediabetesprediabetes
TOPICS
ABSTRACT
Introduction:
The association between red cell distribution width-to-albumin ratio (RAR) and clinical outcomes in cardiovascular disease (CVD) patients with diabetes mellitus (DM) or pre-DM remains unclear, and its underlying mechanisms are not fully understood.
Material and methods:
This population-dependent prospective cohort study enrolled 3224 United States (U.S.) participants from the National Health and Nutrition Examination Survey (NHANES) (2001–2018) who had both CVD and either DM or pre-DM. Using the National Death Index data, the cohort’s mortality outcomes were tracked until December 31, 2019. Cox proportional hazard models and restricted cubic spline regressions were employed to investigate the associations between RAR and mortality outcomes. Notably, mediation analyses were performed to quantify the contribution of inflammatory markers, including neutrophils, monocytes, the neutrophil-to-lymphocyte ratio (NLR), and the systemic immune-inflammation index (SII), in the RAR-mortality relationship.
Results:
During a median 78-month follow-up, 1,223 deaths occurred (483 cardiovascular-related). Elevated RAR was significantly associated with increased all-cause mortality (hazard ratio = 1.43, 95% CI: 1.31–1.56) and cardiovascular mortality (1.44, 1.28–1.62). NLR and SII exhibited significant mediating effects (8.8–10.79% for all-cause; 9.58–11.99% for cardiovascular mortality).
Conclusions:
Elevated RAR was significantly associated with increased risk of all-cause mortality and cardiovascular mortality among patients with CVD and DM or pre-DM. Systemic inflammation significantly mediated these associations. RAR may serve as a practical prognostic marker in this high-risk population.
The association between red cell distribution width-to-albumin ratio (RAR) and clinical outcomes in cardiovascular disease (CVD) patients with diabetes mellitus (DM) or pre-DM remains unclear, and its underlying mechanisms are not fully understood.
Material and methods:
This population-dependent prospective cohort study enrolled 3224 United States (U.S.) participants from the National Health and Nutrition Examination Survey (NHANES) (2001–2018) who had both CVD and either DM or pre-DM. Using the National Death Index data, the cohort’s mortality outcomes were tracked until December 31, 2019. Cox proportional hazard models and restricted cubic spline regressions were employed to investigate the associations between RAR and mortality outcomes. Notably, mediation analyses were performed to quantify the contribution of inflammatory markers, including neutrophils, monocytes, the neutrophil-to-lymphocyte ratio (NLR), and the systemic immune-inflammation index (SII), in the RAR-mortality relationship.
Results:
During a median 78-month follow-up, 1,223 deaths occurred (483 cardiovascular-related). Elevated RAR was significantly associated with increased all-cause mortality (hazard ratio = 1.43, 95% CI: 1.31–1.56) and cardiovascular mortality (1.44, 1.28–1.62). NLR and SII exhibited significant mediating effects (8.8–10.79% for all-cause; 9.58–11.99% for cardiovascular mortality).
Conclusions:
Elevated RAR was significantly associated with increased risk of all-cause mortality and cardiovascular mortality among patients with CVD and DM or pre-DM. Systemic inflammation significantly mediated these associations. RAR may serve as a practical prognostic marker in this high-risk population.
REFERENCES (64)
1.
Mensah GA, Fuster V, Murray CJL, Roth GA, Global Burden of Cardiovascular D, Risks C: Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol 2023; 82: 2350-473.
2.
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2023 Update: a report from the American Heart Association. Circulation 2023; 147: e93-621.
3.
Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007; 115: 114-26.
4.
Kosiborod M, Gomes MB, Nicolucci A, et al. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol 2018; 17: 150.
5.
Honigberg MC, Zekavat SM, Pirruccello JP, Natarajan P, Vaduganathan M. Cardiovascular and kidney outcomes across the glycemic spectrum: insights from the UK Biobank. J Am Coll Cardiol 2021; 78: 453-64.
6.
Yuan T, Yang T, Chen H, et al. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol 2019; 20: 247-60.
7.
Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-30.
8.
Ota T. Immune regulation of glucose and lipid metabolism. Diabetol Int 2017; 8: 257-67.
9.
Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep 2012; 14: 160-6.
10.
Cheung BM, Wat NM, Tso AW, et al. Association between raised blood pressure and dysglycemia in Hong Kong Chinese. Diabetes Care 2008; 31: 1889-91.
11.
Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci 2015; 52: 86-105.
12.
Liang L, Huang L, Zhao X, et al. Prognostic value of RDW alone and in combination with NT-proBNP in patients with heart failure. Clin Cardiol 2022; 45: 802-13.
13.
Cabrerizo S, Cuadras D, Gomez-Busto F, Artaza-Artabe I, Marin-Ciancas F, Malafarina V. Serum albumin and health in older people: review and meta analysis. Maturitas 2015; 81: 17-27.
14.
Seidu S, Kunutsor SK, Khunti K. Serum albumin, cardiometabolic and other adverse outcomes: systematic review and meta-analyses of 48 published observational cohort studies involving 1,492,237 participants. Scand Cardiovasc J 2020; 54: 280-93.
15.
Liao LZ, Zhang SZ, Li WD, Liu Y, Li JP, Zhuang XD, Liao XX. Serum albumin and atrial fibrillation: insights from epidemiological and mendelian randomization studies. Eur J Epidemiol 2020; 35: 113-22.
16.
Kokulu K, Sert ET. The role of the lactate/albumin ratio in predicting survival outcomes in patients resuscitated after out-of-hospital cardiac arrest: a preliminary report. Am J Emerg Med 2021; 50: 670-4.
17.
Li D, Ruan Z, Wu B. Association of red blood cell distribution width-albumin ratio for acute myocardial infarction patients with mortality: a retrospective cohort study. Clin Appl Thromb Hemost 2022; 28: 10760296221121286.
18.
Chen C, Cai J, Song B, et al. Relationship between the ratio of red cell distribution width to albumin and 28-day mortality among chinese patients over 80 years with atrial fibrillation. Gerontology 2023; 69: 1471-81.
19.
Zhao N, Hu W, Wu Z, et al. The red blood cell distribution width-albumin ratio: a promising predictor of mortality in stroke patients. Int J Gen Med 2021; 14: 3737-47.
20.
Huang M, Liu F, Li Z, et al. Relationship between red cell distribution width/albumin ratio and carotid plaque in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China. Cardiovasc Diabetol 2023; 22: 39.
21.
Seo YJ, Yu J, Park JY, et al. Red cell distribution width/albumin ratio and 90-day mortality after burn surgery. Burns Trauma 2022; 10: tkab050.
22.
Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National health and nutrition examination survey: sample design, 2011-2014. Vital Health Stat 2 2014; 162: 1-33.
23.
Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA 2021; 326: 1614-21.
24.
Nguyen VK, Middleton LYM, Huang L, et al. Harmonized US National Health and Nutrition Examination Survey 1988-2018 for high throughput exposome-health discovery. medRxiv 2023. 2023.02.06.23284573. doi: 10.1101/2023.02.06.23284573.
25.
Zou X, Zhou X, Zhu Z, Ji L. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol 2019; 7: 9-11.
26.
Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. Cardiovasc Diabetol 2023; 22: 279.
27.
ICD-10: international statistical classification of diseases and related health problems. In., 10th revision, 2nd ed. edn. Geneva, World Health Organization 2004.
28.
Yu M, Pei L, Liu H, et al. A novel inflammatory marker: relationship between red cell distribution width/albumin ratio and vascular complications in patients with type 2 diabetes mellitus. J Inflamm Res 2024; 17: 6265-76.
29.
Hong J, Hu X, Liu W, et al. Impact of red cell distribution width and red cell distribution width/albumin ratio on all-cause mortality in patients with type 2 diabetes and foot ulcers: a retrospective cohort study. Cardiovasc Diabetol 2022; 21: 91.
30.
Pan LN, Pan SA, Lei BH, Hong GL, Chen KW. Development of a novel nomogram incorporating red blood cell distribution width-albumin ratio for the prediction of 30-day mortality in acute pancreatitis patients. Emerg Med Int 2022; 2022: 1573931.
31.
Hao M, Jiang S, Tang J, et al. Ratio of red blood cell distribution width to albumin level and risk of mortality. JAMA Netw Open 2024; 7: e2413213.
32.
Klisic A, Kavaric N, Stanisic V, et al. Endocan and a novel score for dyslipidemia, oxidative stress and inflammation (DOI score) are independently correlated with glycated hemoglobin (HbA(1c)) in patients with prediabetes and type 2 diabetes. Arch Med Sci 2020; 16: 42-50.
33.
Lee WH, Kipp ZA, Pauss SN, et al. Heme oxygenase, biliverdin reductase, and bilirubin pathways regulate oxidative stress and insulin resistance: a focus on diabetes and therapeutics. Clin Sci (Lond) 2025; 139: 171-98.
34.
Punzo A, Silla A, Fogacci F, Perillo M, Cicero AFG, Caliceti C. Bile Acids and bilirubin role in oxidative stress and inflammation in cardiovascular diseases. Diseases 2024; 12: 103.
35.
Liu Y, Li Z, Xu Y, Mao H, Huang N. Uric acid and atherosclerosis in patients with chronic kidney disease: recent progress, mechanisms, and prospect. Kidney Dis (Basel) 2025; 11: 112-27.
36.
Kopp W. Pathogenesis of (smoking-related) non-communicable diseases-evidence for a common underlying pathophysiological pattern. Front Physiol 2022; 13: 1037750.
37.
Ishida M, Sakai C, Kobayashi Y, Ishida T. Cigarette smoking and atherosclerotic cardiovascular disease. J Atheroscler Thromb 2024; 31: 189-200.
38.
Poznyak AV, Nikiforov NG, Markin AM, et al. Overview of OxLDL and its impact on cardiovascular health: focus on atherosclerosis. Front Pharmacol 2020; 11: 613780.
39.
Madaudo C, Bono G, Ortello A, et al. Dysfunctional high-density lipoprotein cholesterol and coronary artery disease: a narrative review. J Pers Med 2024; 14: 996.
40.
Targonski R, Sadowski J, Starek-Stelmaszczyk M, Targonski R, Rynkiewicz A. Prognostic significance of red cell distribution width and its relation to increased pulmonary pressure and inflammation in acute heart failure. Cardiol J 2020; 27: 394-403.
41.
Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009; 133: 628-32.
42.
Ballmer PE. Causes and mechanisms of hypoalbuminaemia. Clin Nutr 2001; 20: 271-3.
43.
Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med 2012; 7 Suppl 3: S193-9.
44.
Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004; 17: 432-7.
45.
Viasus D, Garcia-Vidal C, Simonetti A, et al. Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia. J Infect 2013; 66: 415-23.
46.
Gaba P, Gersh BJ, Muller J, Narula J, Stone GW. Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research. Nat Rev Cardiol 2023; 20: 181-96.
47.
Maierean S, Webb R, Banach M, Mazidi M. The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events. Eur Heart J Open 2022; 2: oeac039.
48.
Bohula EA, Giugliano RP, Leiter LA, et al. Inflammatory and cholesterol risk in the FOURIER trial. Circulation 2018; 138: 131-40.
49.
Yu M, Yang Y, Dong SL, et al. Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial. Circulation 2024; 150: 981-93.
50.
Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in patients with chronic coronary disease. N Engl J Med 2020; 383: 1838-47.
51.
Tong DC, Quinn S, Nasis A, et al. Colchicine in patients with acute coronary syndrome: the Australian COPS Randomized Clinical Trial. Circulation 2020; 142: 1890-900.
52.
Bytyci I, Bajraktari G, Penson PE, Henein MY, Banach M, Lipid, Blood Pressure Meta-Analysis Collaboration G, International Lipid Expert P. Efficacy and safety of colchicine in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol 2022; 88: 1520-8.
53.
Ridker PM, MacFadyen JG, Everett BM, et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet 2018; 391: 319-28.
54.
Banach M, Surma S, Guzik TJ, et al. Upfront lipid-lowering combination therapy in high cardiovascular risk patients: a route to effective atherosclerotic cardiovascular disease prevention. Cardiovasc Res 2025; 121: 851-9.
55.
Ridker PM, Lei L, Louie MJ, et al.; Investigators CO. Inflammation and cholesterol as predictors of cardiovascular events among 13 970 contemporary high-risk patients with statin intolerance. Circulation 2024; 149: 28-35.
56.
Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98-107.
57.
Grossmann V, Schmitt VH, Zeller T, et al. Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care 2015; 38: 1356-64.
58.
Liberale L, Badimon L, Montecucco F, Luscher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease: JACC Review Topic of the Week. J Am Coll Cardiol 2022; 79: 837-47.
59.
Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011; 11: 519-31.
60.
Gillum RF, Mussolino ME, Madans JH. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 2005; 15: 266-71.
61.
Horne BD, Anderson JL, John JM, et al.; Intermountain Heart Collaborative Study G. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638-43.
62.
Rana JS, Boekholdt SM, Ridker PM, et al. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study. J Intern Med 2007; 262: 678-89.
63.
Wheeler JG, Mussolino ME, Gillum RF, Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 2004; 25: 1287-92.
64.
Chatzigeorgiou A, Karalis KP, Bornstein SR, Chavakis T. Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 2012; 55: 2583-92.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
